Opportunity for Diagnostic Companies in Hospital-Acquired Infections: Kalorama
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 07/14/11 -- When a () is suspected, hospitals need results quickly, which is good news for innovative test makers, notes healthcare market research firm Kalorama Information. In its recent report, Kalorama predicts the combined world market for testing and for HAI will reach $10.3 billion in 2015, up from $9 billion in 2010, with higher growth experienced in the testing segment.
Kalorama's report finds nosocomial infections are an inherent part of any healthcare system and have a 5% infection rate of the 40 million hospital visits a year, causing 100,000 deaths in the U.S. annually. In an effort to decrease the rate of fatality, hospitals are shifting focus towards rapid discovery and treatment of infections, driving sales of testing products.
"The growth opportunities are in testing," said Bruce Carlson, publisher of Kalorama Information. "The treatment market is slowing down, with a little growth in the future, which will be dominated by established pharmaceutical companies."
Specific nosocomial infections that are candidates for testing innovation, include , which comprises nearly 20% of all HAIs with 300,000 cases annually and has an associated mortality rate of 30-70%, as well as , which accounts for nearly 20,000 deaths a year. According to Kalorama, 20-30% of these infections are preventable through intensive hygiene and control programs and the remaining 70-80% through more involved measures, such as hospital architecture and air sanitation and the use of disposable equipment and supplies.
"Everyone is interested in faster tests and immediate results," added Carlson. "Although the rate of infection won't change, quicker turnover will improve patient outcome and drive down mortality rates."
Kalorama Information's report, reveals the world market for HAI diagnostic and treatment markets, providing segmented market data for molecular and conventional testing. It also covers the development of new testing systems and products and provides an analysis on growing drug resistance.
Kalorama Information supplies the latest in independent in , biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on and .
Please direct all media inquiries to:
Andrea Hiller
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.07.2011 - 16:07 Uhr
Sprache: Deutsch
News-ID 34792
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Opportunity for Diagnostic Companies in Hospital-Acquired Infections: Kalorama"
steht unter der journalistisch-redaktionellen Verantwortung von
Kalorama Information (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
